Visit us at the CRS 2025 Annual Meeting and Exposition | Booth 305
What is CRS 2025?
The Controlled Release Society (CRS) Annual Meeting and Exposition brings together scientists, formulators, and industry leaders at the forefront of advanced drug delivery. Hosted in Philadelphia, PA from July 14–18, 2025, the event provides a collaborative forum to share breakthroughs in sustained and targeted release technologies across a range of therapeutic areas.
Date: July 14-18, 2025
Format: In-person
Location: Philadelpia, PA
Booth number: #205
Event website: Event details
Why meet with Thermo Fisher Scientific at CRS 2025?
Controlled release (CR) dosage forms are transforming how therapies are delivered—improving efficacy, supporting patient adherence, and extending product lifecycle value. At CRS 2025, connect with our team to explore how our specialized expertise and integrated services can help you streamline development and scale up with confidence.
Our global network includes dedicated centers of excellence for advanced dosage forms, including our Cincinnati site, which specializes in a full range of CR technologies and formulation strategies such as functional coating, hot melt extrusion, osmotic systems, and multi-particulate designs.
Our activities at CRS 2025
Industry roundtable discussion
Critical considerations, challenges, opportunities, and strategies in development of once-- day (QD) formulations
Date: Wednesday, July 16, 2025
Time: 1:00 PM - 2:30 PM EDT
Location: Philadelphia, PA
Thermo Fisher Scientific’s Dr. Anil Kane, Head of Global Technical Scientific Affairs, and Tracy Danneker, Senior sales development representative ODD will be joined by Dr. Firouz Asgarzadeh, Lead Product Development Consultant at Sagimet, and Dr. Sandip Tiwari, Head of Technical Services – Pharma Solutions NA at BASF, for a dynamic conversation exploring formulation strategies, development hurdles, and commercialization insights for QD drug products.
Meet round table panelists
Dr. Anil Kane
Head of Global Technical and Scientific Affairs, Thermo Fisher Scientific
Dr. Kane brings over 30 years of experience in drug development, with expertise spanning early-stage formulation, scale-up, commercial manufacturing, and global technology transfers. He is recognized for his leadership in navigating complex development pathways and life cycle management for pharmaceutical products.
Firouz Asgarzadeh, Ph.D., is the founder of OSD Pharmaceutical Solutions LLC, an independent consulting firm providing formulation and process development services to pharmaceutical companies. With over 29 years of global R&D and commercial leadership experience, he is a key opinion leader (KOL) in formulation development, controlled release, modified release coating, solubility enhancement, oral/injectable sustained release dosage development, polymer synthesis, and processing.
Head of Technical Services – Pharma Solutions North America, BASF
Dr. Sandip Tiwari leads technical services for Pharma Solutions at BASF in North America, partnering with (bio)pharmaceutical companies to address formulation and processing challenges. He is the author of one book, multiple book chapters, and more than 100 publications and patents in dosage form design, excipient innovation, dissolution science, and mathematical modeling.
Senior Sales Representative, Oral Drug Delivery, Thermo Fisher Scientific
Since 2022, Tracy Danneker has led commercial operations for Oral Drug Delivery at Thermo Fisher Scientific, supporting pharma and biotech innovators from early development through commercialization. She is passionate about guiding customers through the drug development lifecycle to help bring transformative therapies to patients.
Poster and oral poster presentations
Our scientists will be sharing new research across controlled release strategies and development best practices. Learn more about their sessions below.
Oral presentations
Title: Manufacturing Process Design: Scaling up studies for success
Presenter: Dr. Giuseppina G.S. Salzano, Head of Formulation & Analytical Development, Thermo Fisher Scientific
Title: A scale-independent approach to enable the continuous manufacturing of nanosuspensions
Presenter: Dr. Felipe M. González-Fernández, Formulation Scientist, Thermo Fisher Scientific
Poster presentations
Title: How to make robust a commercial peptide-based lyophilized formulation
Presenter: Fabio F.S. Selis, Formulation Scientist Lead, Thermo Fisher Scientific
Thermo Fisher Scientific’s Dr. Anil Kane, Head of Global Technical Scientific Affairs, and Tracy Danneker, Senior sales development representative ODD will be joined by Dr. Firouz Asgarzadeh, Lead Product Development Consultant at Sagimet, and Dr. Sandip Tiwari, Head of Technical Services – Pharma Solutions NA at BASF, for a dynamic conversation exploring formulation strategies, development hurdles, and commercialization insights for QD drug products.
Workshop
Oral drug delivery-technology of today and tomorrow
Title: Understanding commercial CMC in complex formulations
Speaker: Anil Kane
Date: Monday, July 14th, 2025
Time: 1:20 PM - 1:40PM EDT
Location: Philadelphia, PA
Thermo Fisher Scientific’s Dr. Anil Kane, Head of Global Technical Scientific Affairs, and Tracy Danneker, Senior sales development representative ODD will be joined by Dr. Firouz Asgarzadeh, Lead Product Development Consultant at Sagimet, and Dr. Sandip Tiwari, Head of Technical Services – Pharma Solutions NA at BASF, for a dynamic conversation exploring formulation strategies, development hurdles, and commercialization insights for QD drug products.
Let’s connect in Philadelphia
We look forward to connecting with you at the Festival of Biologics 2025—your key to unlocking faster biologics development.
Visit us at booth #305 to speak with our experts, explore recent case studies, and learn how we can support your controlled release goals—from feasibility to commercial launch.